Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain

AIDS Research and Human Retroviruses

Volumn 28, Issue 9, 2012, Pages 889-894

  Arredondo, Miguel ^a   Hackett, John ^b   De Bethencourt, Fermín R ^a   Treviño, Ana ^a   Escudero, Domingo ^c   Collado, Antonio ^d   Qiu, Xiaoxing ^b   Swanson, Priscilla ^b   Soriano, Vincent ^a   De Mendoza, Carmen ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b ABBOTT DIAGNOSTICS   (United States)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PROTEIN P15; VIRUS ENVELOPE PROTEIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC FATIGUE SYNDROME; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; GENE SEQUENCE; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RETROVIRUS INFECTION; SPAIN; VIRUS HEPATITIS; XENOTROPIC MULV RELATED VIRUS;

EID: 84865114337     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0149     Document Type: Article

References (36)

1. Urisman A, Molinaro R, Fischer N, et al.: Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006;2:e25.
2. Lombardi V, Ruscetti F, Das Gupta J, et al.: Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009;326:585-589.
3. Schlaberg R, Choe D, Brown K, et al.: XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci USA 2009;106:16351-16356.
4. Arnold R, Makarova N, Osunkoya A, et al.: XMRV infection in patients with prostate cancer: Novel serologic assay and correlation with PCR and FISH. Urology 2010;75: 755-761.
5. Danielson B, Ayala G, and Kimata J: Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J Infect Dis 2010;15;202:1470-1477.
6. Fischer N, Hellwinkel O, Schulz C, et al.: Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 2008;43:277-283.
7. Hohn O, Krause H, Barbarotto P, et al.: Lack of evidence for xenotropic murine leukaemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology 2009;6:92.
8. Verhaegh G, de Jong A, Smit F, Jannink S, Melchers W, and Schalken J: Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients. Prostate 2011;71(4):415-420.
9. Groom H, Boucherit V, Makinson K, et al.: Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 2010;7:10.
10. Erlwein O, Kaye S, McClure M, et al.: Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 2010;5:e8519.
11. Van Kuppeveld F, de Jong A, Lanke K, et al.: Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: Retrospective analysis of samples from an established cohort. BMJ 2010;340:c1018.
12. Switzer W, Jia H, Hohn O, et al.: Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology 2010;7:57.
13. Henrich T, Li J, Felsenstein D, et al.: Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. J Infect Dis 2010;202:1478-1481.
14. Hong P, Li J, and Li Y: Failure to detect xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol J 2010;7:224.
15. Lo S, Pripuzova N, Li B, et al.: Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci USA 2010;107:15874-15879.
16. Silverman R, Nguyen C, Weight C, and Klein E: The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome. Nat Rev Urol 2010;7:392-402.
17. Paprotka T, Venkatachari N, Chaipan C, et al.: Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J Virol 2010;84:5719-5729.
18. Singh I, Gorzynski J, Drobysheva D, Bassit L, and Schinazi R: Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome. PLoS One 2010;5:e9948.
19. Smith S, Gottlieb G, and Miller A: Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors. Retrovirology 2010;7:70.
20. Fukuda K, Straus S, Hickie I, Sharpe M, Dobbins J, and Komaroff A: The chronic fatigue syndrome-a comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-959. (Pubitemid 24370860)
21. Qiu X, Swanson P, Luk K, et al.: Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies. Retrovirology 2010;7:68.
22. Knouf E, Metzger M, Mitchell P, et al.: Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J Virol 2009;83:7353-7356.
23. Sharma P, Suppiah S, Molinaro R, et al.: Organ and cell lineage dissemination of XMRV in rhesus macaques during acute and chronic Infection [abstract 150LB]. In: Program and Abstracts of the 17th Conference on Retroviruses and Opportunistic Infections, 2010, San Francisco, CA.
24. Dodd R, Hackett J Jr, Linnen J, et al.: XMRV does not pose a risk to blood recipient safety. Transfusion 2012; 52:298-306.
25. Smith R: Contamination of clinical specimens with MLVencoding nucleic acids: Implications for XMRV and other candidate human retroviruses. Retrovirology 2010;7:112.
26. Robinson M, Erlwein O, Kaye S, et al.: Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 2010;7:108.
27. Oakes B, Tai A, Cingoz O, et al.: Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 2010;7:109.
28. Hue S, Gray E, Gall A, et al.: Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010;7:111.
29. Knox K, Carrigan D, Simmons G, et al.: No evidence of murine-like gammaretroviruses in CSF patients previously identified as XMRV-infected. Science 2011;333:94-97.
30. Simmons G, Glynn S, Komaroff A, et al.: Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: A multi-laboratory study. Science 2011;334:814-817.
31. Paprotka T, Delviks-Frankenberry K, Cingoz O, et al.: XMRV probably originated through recombination between 2 endogenous murine retroviruses during in vivo passage of a human prostate cancer xenograft [abstract 91LB]. In: Program and Abstracts of the 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February, 2011.
32. Cingoz O and Coffin J: Identification of a novel endogenous murine leukemia virus as an XMRV ancestor [abstract 223]. In: Program and Abstracts of the 18th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February, 2011.
33. Mikovits J, Huang Y, Pfost M, et al.: Distribution of xenotropic murine leukemia virus-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer. AIDS Rev 2010;12:149-152.
34. Mikovits J, Lombardi V, Pfost M, Hagen K, and Ruscetti F: Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Virulence 2010;1: 386-390.
35. Weiss R: A cautionary tale of virus and disease. BMC Biol 2010;8:124-128.
36. Menéndez-Arias L: Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome. Rev Med Virol 2011;21:3-17.